A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
The non-Responsiveness to Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Neovascularage-Related Macular Degeneration
2017
Advances in Ophthalmology & Visual System
Preserved Fulltext
In this editorial, the definition and potential risk factors of the non-responsiveness to the intravitreal applications of anti-vascular endothelial growth factors in the patients with neovascular age-related macular degeneration were summarized. To know the potential risk factors for the non-responsiveness to these agents may prevent unnecessary treatment interventions and unrealistic patient expectations.
doi:10.15406/aovs.2017.06.00202
fatcat:36fpi3akz5f6zlezzieasxldoa